PADI4

From Wikipedia, the free encyclopedia


Peptidyl arginine deiminase, type IV
PDB rendering based on 1wd8.
Available structures: 1wd8, 1wd9, 1wda, 2dew, 2dex, 2dey, 2dw5
Identifiers
Symbol(s) PADI4; PAD; PADI5; PDI4; PDI5
External IDs OMIM: 605347 MGI1338898 HomoloGene7883
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 23569 18602
Ensembl ENSG00000159339 ENSMUSG00000025330
Uniprot Q9UM07 Q9Z183
Refseq NM_012387 (mRNA)
NP_036519 (protein)
XM_991479 (mRNA)
XP_996573 (protein)
Location Chr 1: 17.51 - 17.56 Mb Chr 4: 140.02 - 140.05 Mb
Pubmed search [1] [2]

Peptidyl arginine deiminase, type IV, also known as PADI4, is a human gene.[1]

This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response.[1]

[edit] References

[edit] Further reading

  • Nakashima K, Hagiwara T, Ishigami A, et al. (1999). "Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3).". J. Biol. Chem. 274 (39): 27786-92. PMID 10488123. 
  • Zhang QH, Ye M, Wu XY, et al. (2001). "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.". Genome Res. 10 (10): 1546-60. PMID 11042152. 
  • Asaga H, Nakashima K, Senshu T, et al. (2001). "Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils.". J. Leukoc. Biol. 70 (1): 46-51. PMID 11435484. 
  • Nakashima K, Hagiwara T, Yamada M (2003). "Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes.". J. Biol. Chem. 277 (51): 49562-8. doi:10.1074/jbc.M208795200. PMID 12393868. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Suzuki A, Yamada R, Chang X, et al. (2003). "Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.". Nat. Genet. 34 (4): 395-402. doi:10.1038/ng1206. PMID 12833157. 
  • Barton A, Bowes J, Eyre S, et al. (2004). "A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population.". Arthritis Rheum. 50 (4): 1117-21. doi:10.1002/art.20169. PMID 15077293. 
  • Chavanas S, Méchin MC, Takahara H, et al. (2004). "Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.". Gene 330: 19-27. doi:10.1016/j.gene.2003.12.038. PMID 15087120. 
  • Arita K, Hashimoto H, Shimizu T, et al. (2004). "Structural basis for Ca(2+)-induced activation of human PAD4.". Nat. Struct. Mol. Biol. 11 (8): 777-83. doi:10.1038/nsmb799. PMID 15247907. 
  • Hoppe B, Heymann GA, Tolou F, et al. (2005). "High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach.". J. Mol. Med. 82 (11): 762-7. doi:10.1007/s00109-004-0584-6. PMID 15338034. 
  • Cuthbert GL, Daujat S, Snowden AW, et al. (2004). "Histone deimination antagonizes arginine methylation.". Cell 118 (5): 545-53. doi:10.1016/j.cell.2004.08.020. PMID 15339660. 
  • Wang Y, Wysocka J, Sayegh J, et al. (2004). "Human PAD4 regulates histone arginine methylation levels via demethylimination.". Science 306 (5694): 279-83. doi:10.1126/science.1101400. PMID 15345777. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Nakayama-Hamada M, Suzuki A, Kubota K, et al. (2005). "Comparison of enzymatic properties between hPADI2 and hPADI4.". Biochem. Biophys. Res. Commun. 327 (1): 192-200. doi:10.1016/j.bbrc.2004.11.152. PMID 15629448. 
  • Lee YH, Coonrod SA, Kraus WL, et al. (2005). "Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.". Proc. Natl. Acad. Sci. U.S.A. 102 (10): 3611-6. doi:10.1073/pnas.0407159102. PMID 15731352. 
  • Kearney PL, Bhatia M, Jones NG, et al. (2005). "Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.". Biochemistry 44 (31): 10570-82. doi:10.1021/bi050292m. PMID 16060666. 
  • Ikari K, Kuwahara M, Nakamura T, et al. (2005). "Association between PADI4 and rheumatoid arthritis: a replication study.". Arthritis Rheum. 52 (10): 3054-7. doi:10.1002/art.21309. PMID 16200584. 
  • Chang X, Han J (2006). "Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.". Mol. Carcinog. 45 (3): 183-96. doi:10.1002/mc.20169. PMID 16355400. 
  • Plenge RM, Padyukov L, Remmers EF, et al. (2006). "Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.". Am. J. Hum. Genet. 77 (6): 1044-60. doi:10.1086/498651. PMID 16380915. 
  • Hoppe B, Häupl T, Gruber R, et al. (2006). "Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.". Arthritis Res. Ther. 8 (2): R34. doi:10.1186/ar1889. PMID 16469113.